Chemours shows prevailing Real Value of $29.63 per share. The current price of the firm is $16.35. At this time the firm appears to be undervalued. This module approximates value of Chemours from analyzing the firm fundamentals such as Return On Equity of
65.37% and Profit Margin of 10.31% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
September 17, 2019
Chemours is slightly risky asset. Calculation of real value of Chemours is based on 3 months time horizon. Increasing Chemours time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Valuation Drivers Correlation
|Click cells to compare fundamentals||View All Correlations|
Chemours Market CapChemours Company is rated fifth in market capitalization category among related companies. Market capitalization of Specialty Chemicals industry is currently estimated at about 83.98 Billion. Chemours holds roughly 2.79 Billion in market capitalization claiming about 3% of equities listed under Specialty Chemicals industry.
|Horizon||30 Days Login to change|
Chemours Company is rated below average in price to sales category among related companies. It is rated fourth in price to book category among related companies fabricating about 7.06 of Price to Book per Price to Sales.
|Price to Sales ( times )|
|Price to Book ( times )|